125 related articles for article (PubMed ID: 34331942)
21. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Cooper A; Capewell P; Clucas C; Veitch N; Weir W; Thomson R; Raper J; MacLeod A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004903. PubMed ID: 27494254
[TBL] [Abstract][Full Text] [Related]
22. Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease.
McCarthy GM; Blasio A; Donovan OG; Schaller LB; Bock-Hughes A; Magraner JM; Suh JH; Tattersfield CF; Stillman IE; Shah SS; Zsengeller ZK; Subramanian B; Friedman DJ; Pollak MR
Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34350953
[TBL] [Abstract][Full Text] [Related]
23. Decoding the network of Trypanosoma brucei proteins that determines sensitivity to apolipoprotein-L1.
Currier RB; Cooper A; Burrell-Saward H; MacLeod A; Alsford S
PLoS Pathog; 2018 Jan; 14(1):e1006855. PubMed ID: 29346416
[TBL] [Abstract][Full Text] [Related]
24. All You Ever Wanted to Know About APOL1 and TLFs and Did Not Dare Ask.
Verdi J; Schaub C; Thomson R; Raper J
Methods Mol Biol; 2020; 2116():463-483. PubMed ID: 32221937
[TBL] [Abstract][Full Text] [Related]
25. Interplay of Trypanosome Lytic Factor and innate immune cells in the resolution of cutaneous Leishmania infection.
Pant J; Samanovic M; Nelson MT; Keceli MK; Verdi J; Beverley SM; Raper J
PLoS Pathog; 2021 Sep; 17(9):e1008768. PubMed ID: 34559857
[TBL] [Abstract][Full Text] [Related]
26.
Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
Elife; 2017 May; 6():. PubMed ID: 28537557
[TBL] [Abstract][Full Text] [Related]
27. Evolution of the primate trypanolytic factor APOL1.
Thomson R; Genovese G; Canon C; Kovacsics D; Higgins MK; Carrington M; Winkler CA; Kopp J; Rotimi C; Adeyemo A; Doumatey A; Ayodo G; Alper SL; Pollak MR; Friedman DJ; Raper J
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2130-9. PubMed ID: 24808134
[TBL] [Abstract][Full Text] [Related]
28. [Molecular dialogue between African trypanosomes and humans].
Pays E
Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
[TBL] [Abstract][Full Text] [Related]
29. ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
O'Toole JF; Schilling W; Kunze D; Madhavan SM; Konieczkowski M; Gu Y; Luo L; Wu Z; Bruggeman LA; Sedor JR
J Am Soc Nephrol; 2018 Mar; 29(3):869-879. PubMed ID: 29180397
[TBL] [Abstract][Full Text] [Related]
30. APOL1 Kidney Risk Variants Induce Cell Death
Shah SS; Lannon H; Dias L; Zhang JY; Alper SL; Pollak MR; Friedman DJ
J Am Soc Nephrol; 2019 Dec; 30(12):2355-2368. PubMed ID: 31558683
[TBL] [Abstract][Full Text] [Related]
31. APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
Uzureau S; Lecordier L; Uzureau P; Hennig D; Graversen JH; Homblé F; Mfutu PE; Oliveira Arcolino F; Ramos AR; La Rovere RM; Luyten T; Vermeersch M; Tebabi P; Dieu M; Cuypers B; Deborggraeve S; Rabant M; Legendre C; Moestrup SK; Levtchenko E; Bultynck G; Erneux C; Pérez-Morga D; Pays E
Cell Rep; 2020 Mar; 30(11):3821-3836.e13. PubMed ID: 32187552
[TBL] [Abstract][Full Text] [Related]
32. Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.
Harrington JM; Howell S; Hajduk SL
J Biol Chem; 2009 May; 284(20):13505-13512. PubMed ID: 19324878
[TBL] [Abstract][Full Text] [Related]
33. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
34. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
35. Transcription and translation of
Ejaz S
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842513
[TBL] [Abstract][Full Text] [Related]
36. Human innate immunity against African trypanosomes.
Pays E; Vanhollebeke B
Curr Opin Immunol; 2009 Oct; 21(5):493-8. PubMed ID: 19559585
[TBL] [Abstract][Full Text] [Related]
37. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
[TBL] [Abstract][Full Text] [Related]
38. The Pathogenesis of African Trypanosomiasis.
Pays E; Radwanska M; Magez S
Annu Rev Pathol; 2023 Jan; 18():19-45. PubMed ID: 36055769
[TBL] [Abstract][Full Text] [Related]
39. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization.
Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM
J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766
[TBL] [Abstract][Full Text] [Related]
40. APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H; Kumar V; Lan X; Shoshtari SSM; Eng JM; Zhou X; Wang F; Wang H; Skorecki K; Xing G; Wu G; Luo H; Malhotra A; Singhal PC
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29967295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
